Media Database
>
Matthew Partridge

Matthew Partridge

Senior Writer at MoneyWeek (UK)

Contact this person
Email address
m*****@*******.comGet email address
Influence score
36
Phone
(XXX) XXX-XXXX Get mobile number
Location
United Kingdom
Languages
  • English
Covering topics
  • General Assignment News
  • Finance & Banking Services

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

moneyweek.com

Walgreens Boots Alliance sold to private equity firm - will Boots get the boot?

US pharmacy giant Walgreens Boots Alliance is going private. Will the new owners sell off the high-street chemist?
moneyweek.com

What does a potential BP and Shell merger mean for the UK oil indus...

BP’s struggles have made it vulnerable to a takeover. Could it merge with Shell to create a British behemoth?
moneyweek.com

Why Sezzle's shares may be overvalued

Sezzle, the US buy-now-pay-later provider, is resting on shaky foundations. Is it time to sell this stock?
moneyweek.com

What MoneyWeek writers read and watched in 2024

Here's a roundup of MoneyWeek's favourite books, films and TV shows in 2024
moneyweek.com

Royal Mail takeover by Czech billionaire approved for £3.6bn

Czech billionaire Czech billionaire Daniel Kretinsky now owns Royal Mail, following a £3.6 billion takeover
moneyweek.com

Invest in sports: how to profit from the booming global industry

Whether it’s backing sports teams, the media networks that buy the rights or the firms that make the clobber, opportunities abound for investors
moneyweek.com

Shares in luxury goods companies take a hit – will they recover?

Luxury goods companies have run into trouble, and the odds of a rapid recovery have receded. What next?
moneyweek.com

Nestlé is in trouble as it pushes prices up

Nestlé has pushed up prices for customers and now it's suffering the consequences, leaving a spotlight on its performance and shares
moneyweek.com

Pfizer shares rise as US investor takes $1 billion stake

Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
moneyweek.com

Harworth doubles profit as revenue soars — should you buy?

Harworth, a specialist property developer, is well-aligned with government policies, with revenue expected to rise by over 50% this year, and a further 30% the year after.
moneyweek.com

Shares in gambling group Entain rise

Shares in Entain rose by 5% after three years of the stock sliding. Is more luck on the cards for the gambling group?